PAIA
PFE icon

Park Avenue Institutional Advisers’s Pfizer PFE Stock Holding History

Park Avenue Institutional Advisers’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-40,195
Closed -$1.34M – 310
2016
Q2 		$1.34M Sell
40,195
-791
-2% -$25.2K 1.15% 14
2016
Q1 		$1.15M Sell
40,986
-1,153
-3% -$32.9K 1% 16
2015
Q4 		$1.29M Sell
42,139
-1,098
-3% -$34.5K 1.11% 15
2015
Q3 		$1.29M Sell
43,237
-323
-0.7% -$10.4K 1.14% 13
2015
Q2 		$1.39M Buy
+43,560
New +$1.42M 1.12% 11

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Park Avenue Institutional Advisers's PFE Position: Q3 2016 in Review

Park Avenue Institutional Advisers sold out of Pfizer (PFE) in Q3 2016, closing a stake of 40,195 shares — an estimated $1.34M sold.

Park Avenue Institutional Advisers first reported a position in PFE in Q2 2015 and held it in 5 quarters. The position peaked at $1.39M in Q2 2015. 1,962 funds tracked by Wall St. Rank hold PFE as of Q3 2016.

  • Park Avenue Institutional Advisers reported no remaining Pfizer position as of Q3 2016 after selling out during the quarter.
  • Park Avenue Institutional Advisers sold 40,195 Pfizer shares in Q3 2016, an estimated $1.34M.
  • Park Avenue Institutional Advisers first reported a position in Pfizer in Q2 2015 and held it in 5 quarters.
  • Park Avenue Institutional Advisers's Pfizer position peaked at $1.39M in Q2 2015.
  • 1,962 funds tracked by Wall St. Rank held Pfizer as of Q3 2016.

Based on Park Avenue Institutional Advisers's 13F filing for Q3 2016, filed 15 Feb 2017.